We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Global Molecular Transplant Diagnostics Market to Triple Revenue

By LabMedica International staff writers
Posted on 09 May 2017
Print article
Image: The global market for molecular transplant diagnostics is projected to grow at an average annual rate of 9% up to 2021 (Photo courtesy of Kalorama Information).
Image: The global market for molecular transplant diagnostics is projected to grow at an average annual rate of 9% up to 2021 (Photo courtesy of Kalorama Information).
The global market for molecular transplant diagnostics is estimated to be over USD 300 million and is projected to grow at an average annual rate of 9% up to 2021. These are the latest findings of Kalorama Information, an independent medical market research firm.

Molecular testing technologies are well suited for solid organ and hematopoietic stem cell (HSCT) or bone marrow transplants, which require histocompatibility between the recipient and donor for successful outcomes. The various PCR-based methodologies, Sanger sequencing and NGS used to type HLA alleles in low to high resolution in order to match donors and recipients for solid organ and HSCT or bone marrow transplants; post-transplant monitoring including for transplant rejection is an ancillary testing area. Allogenic HSCT transplantation is a comparatively high growth procedure area in comparison to solid organ transplantation and is a leading area of application for molecular HLA typing.

Over allogenic 9,000 HSCTs and approximately 30,000 solid organ transplants are performed in the US each year, making it the world’s largest market for molecular transplant diagnostics. The large size of the US molecular transplant diagnostics market is sustained by the demand for high resolution molecular HLA typing, including sequencing-based methods. In Europe, over 30,000 solid organ transplants and around 18,000 HSCTs are performed each year with transplant volumes in the region continuing to grow at a faster pace as compared to the US. This is due to the higher number of solid organ transplants and HSCTs being performed in the Eastern European countries and other less mature markets, thereby driving sales of test products.

"Molecular is not ubiquitous, as some forecasters – including us- may have thought a decade ago," said Bruce Carlson, Publisher of Kalorama Information. "It performs well in areas where it is set apart from other technologies. HLA is a value-add area for molecular, and you see that in the growth rate."

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.